학술논문
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
Document Type
Artikel
Author
Ascierto, PA; Casula, M; Bulgarelli, J; Pisano, M; Piccinini, C; Piccin, L; Cossu, A; Mandalà, M; Ferrucci, PF; Guidoboni, M; Rutkowski, P; Ferraresi, V; Arance, A; Guida, M; Maiello, E; Gogas, H; Richtig, E; Fierro, MT; Lebbe, C; Helgadottir, H; Queirolo, P; Spagnolo, F; Tucci, M; Del Vecchio, M; Cao, MG; Minisini, AM; De Placido, S; Sanmamed, MF; Mallardo, D; Paone, M; Vitale, MG; Melero, I; Grimaldi, AM; Giannarelli, D; Dummer, R; Sileni, VC; Palmieri, G
Source
Nature communications. 15(1):146
Subject
Language
English
English
English
ISSN
2041-1723